Thermo Fisher Scientific Inc's stock ($TMO) has been actively traded, with a mixture of buying and selling by various investment firms and banks. This includes ST Germain D J Co. Inc. and Dakota Wealth Management selling shares, while Eagle Global Advisors and Evergreen Private Wealth have boosted their stake in TMO. New product launches and expanded distribution deals have brought TMO's valuation into focus. Despite some firms like the First American Bank decreasing its stock holdings in TMO, others such as Howard Capital Management Group and the BOS Asset Management have initiated or increased their positions respectively. In contrast, the State of Alaska's Department of Revenue and Banque Pictet & Cie SA reduced their TMO holdings. Furthermore, Thermo Fisher has expanded its product portfolio with the launch of the Thermo Scientific Hypulse Surface Analysis System. Analysts are also indicating a bullish outlook for the company, citing its strong Q2 performance and increased outlook, along with its wide economic moat and potential for multi-year growth.
